Literature DB >> 7791149

Phosphodiesterase inhibitor pentoxifylline: an antiinflammatory/immunomodulatory drug potentially useful in some rheumatic diseases.

J M Anaya, L R Espinoza.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7791149

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  8 in total

1.  CD14+CD16+ monocyte subpopulation in Kawasaki disease.

Authors:  K Katayama; T Matsubara; M Fujiwara; M Koga; S Furukawa
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

2.  IL-1 beta- and IL-4-induced down-regulation of autotaxin mRNA and PC-1 in fibroblast-like synoviocytes of patients with rheumatoid arthritis (RA).

Authors:  A Kehlen; R Lauterbach; A N Santos; K Thiele; U Kabisch; E Weber; D Riemann; J Langner
Journal:  Clin Exp Immunol       Date:  2001-01       Impact factor: 4.330

3.  Pentoxifylline modulates LPS-induced hyperinflammation in monocytes of preterm infants in vitro.

Authors:  Simone S Schüller; Lukas Wisgrill; Elisabeth Herndl; Andreas Spittler; Elisabeth Förster-Waldl; Kambis Sadeghi; Boris W Kramer; Angelika Berger
Journal:  Pediatr Res       Date:  2017-05-24       Impact factor: 3.756

4.  Prostaglandin E2 differentially modulates proinflammatory/prodestructive effects of TNF-alpha on synovial fibroblasts via specific E prostanoid receptors/cAMP.

Authors:  Elke Kunisch; Anne Jansen; Fumiaki Kojima; Ivonne Löffler; Mohit Kapoor; Shinichi Kawai; Ignacio Rubio; Leslie J Crofford; Raimund W Kinne
Journal:  J Immunol       Date:  2009-06-19       Impact factor: 5.422

5.  Immunotherapeutic effects of pentoxifylline in type 1 diabetic mice and its role in the response of T-helper lymphocytes.

Authors:  Farin Malekifard; Nowruz Delirezh; Rahim Hobbenaghi; Hassan Malekinejad
Journal:  Iran J Basic Med Sci       Date:  2015-03       Impact factor: 2.699

6.  Rationale of combination therapy with antioxidants in medical management of Peyronie's disease: results of clinical application.

Authors:  Gianni Paulis; Andrea Paulis; Gennaro Romano; Davide Barletta; Andrea Fabiani
Journal:  Res Rep Urol       Date:  2017-07-20

Review 7.  Recent Pathophysiological Aspects of Peyronie's Disease: Role of Free Radicals, Rationale, and Therapeutic Implications for Antioxidant Treatment-Literature Review.

Authors:  Gianni Paulis; Gennaro Romano; Luca Paulis; Davide Barletta
Journal:  Adv Urol       Date:  2017-07-04

Review 8.  Immunomodulation to Prevent or Treat Neonatal Sepsis: Past, Present, and Future.

Authors:  Simone S Schüller; Boris W Kramer; Eduardo Villamor; Andreas Spittler; Angelika Berger; Ofer Levy
Journal:  Front Pediatr       Date:  2018-07-19       Impact factor: 3.418

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.